TITILOPE FASIPE to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications TITILOPE FASIPE has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.541
-
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series. Pediatr Blood Cancer. 2024 Aug; 71(8):e31061.
Score: 0.415
-
Clinical Practice Patterns in Sickle Cell Disease Treatment: Disease-modifying and Potentially Curative Therapies. J Pediatr Hematol Oncol. 2024 07 01; 46(5):e277-e283.
Score: 0.103
-
Sickle Cell Disease: A Review. JAMA. 2022 07 05; 328(1):57-68.
Score: 0.023